A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma
NCT02460991
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class
Stopped
Slow enrollment
Conditions
Hepatocellular Carcinoma
Hepatoma
Liver Cell Carcinoma
Interventions
DEVICE:
DEB-TACE
DRUG:
Sorafenib
Sponsor
Boston Scientific Corporation